Changeflow GovPing Pharma & Drug Safety USPTO Patent Grant: Canine TK1 Protein Determin...
Routine Notice Added Final

USPTO Patent Grant: Canine TK1 Protein Determination Kit

Favicon for changeflow.com ChangeBridge: Patent Grants - Peptides (C07K)
Published March 17th, 2026
Detected March 22nd, 2026
Email

Summary

The USPTO has granted patent US12578340B2 to ALERTIX VETERINARY DIAGNOSTICS AB for a kit to determine canine TK1 protein levels. The kit utilizes specific monoclonal antibodies to detect peptides from canine TK1.

What changed

The United States Patent and Trademark Office (USPTO) has issued patent US12578340B2, titled 'Canine TK1 protein level determination kit disclosed,' to ALERTIX VETERINARY DIAGNOSTICS AB. The patent describes a kit comprising monoclonal antibodies designed to detect specific peptides within canine TK1, a protein relevant in veterinary diagnostics. The patent was granted on March 17, 2026, with a filing date of June 2, 2023, and application number 18328056.

This patent grant signifies the USPTO's recognition of novel technology in the field of veterinary diagnostics. While not imposing direct regulatory obligations on companies, it establishes intellectual property rights for the assignee. Companies operating in veterinary diagnostics, particularly those developing or utilizing similar protein detection kits, should be aware of this patent to ensure they do not infringe on the granted claims. No immediate compliance actions are required for entities not involved in the development or sale of this specific technology.

Source document (simplified)

← USPTO Patent Grants

Determination of canine TK1 protein levels

Grant US12578340B2 Kind: B2 Mar 17, 2026

Assignee

ALERTIX VETERINARY DIAGNOSTICS AB

Inventors

Staffan Eriksson, Henrik Rönnberg, Kiran Kumar Jagarlamudi

Abstract

A kit useful for determination of canine TK1 in a sample is disclosed. The kit comprises a first monoclonal antibody, or a fragment thereof, immobilized to a support or intended to be immobilized to a support. The kit also comprises a second monoclonal antibody, or a fragment thereof. One of the monoclonal antibodies has specificity for a peptide consisting of an amino acid sequence from a C-terminal region of canine TK1 and the other monoclonal antibody has specificity for a peptide consisting of an amino acid sequence from an active site of TK1.

CPC Classifications

C07K 16/40 C07K 16/18 C07K 2317/20 C07K 2317/34 G01N 33/541 G01N 33/5434 G01N 33/573 G01N 33/574 G01N 2800/52 G01N 2800/54

Filing Date

2023-06-02

Application No.

18328056

Claims

17

View original document →

Named provisions

Determination of canine TK1 protein levels

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
March 17th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12578340B2

Who this affects

Applies to
Drug manufacturers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Diagnostic Kit Development
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Research & Development
Topics
Diagnostics Veterinary Medicine

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.